Lifecore Biomedical

Activity by year

2026

AcquisitionContract

Sep 28, 2026ACQUISITIONChaska, Minnesota, United States$663.7M
Lifecore Biomedical to be acquired by Webster Equity Partners for up to $663.7M
Lifecore Biomedical has entered into a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, including contingent value rights. Common stockholders will receive $6.28 per share in cash.
Webster Equity Partners acquirer Lifecore Biomedical target #Medical Devices globenewswire.com ir.lifecore.com app.readthrough.bio
Sep 24, 2026CONTRACTUnited States
Lifecore extends Alcon manufacturing agreement to 2034
Lifecore Biomedical signed a Third Amendment to its contract manufacturing agreement with Alcon Research, extending the Initial Term from December 31, 2031 to December 31, 2034. The amendment also revises Alcon's minimum purchase commitments through 2034.
Lifecore Biomedical supplier Alcon Research customer #Medical Devices app.readthrough.bio

Customers

Acquired by

Loading…